← Back to catalogue

Bzg

FDA UDI

Class II (US FDA UDI)

by Randox Laboratories, Ltd.

Identity

Trade Name
BZG FDA UDI
Generic Name
Cocaine/cocaine metabolite IVD, reagent FDA UDI
Device Name
The Cocaine assay is an in vitro diagnostic test for the qualitative and semi-quantitative detection of benzoylecgonine (Cocaine Metabolite) in human urine. FDA UDI
Model / Reference
DA4011 FDA UDI
Description
The Cocaine assay is an in vitro diagnostic test for the qualitative and semi-quantitative detection of benzoylecgonine (Cocaine Metabolite) in human urine. FDA UDI

Identifiers

Catalog Number
DA4011 FDA UDI
Primary DI / UDI-DI
05055273208047 FDA UDI
510(k) Number
K113751 FDA UDI
FDA Product Code
DIO FDA UDI
GMDN Term
Cocaine/cocaine metabolite IVD, reagent FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.3250 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Cocaine/cocaine metabolite IVD, reagent

Bzg by Randox Laboratories, Ltd. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Cocaine/cocaine metabolite IVD, reagent.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 83ff6c99-b409-427d-8312-fd64b74e86c5 37 fields · synced Jun 6, 2026